A detailed history of Coastwise Capital Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Coastwise Capital Group, LLC holds 12,305 shares of MRK stock, worth $1.02 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
12,305
Previous 5,439 126.24%
Holding current value
$1.02 Million
Previous $541,000 104.07%
% of portfolio
0.94%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$83.01 - $101.02 $569,946 - $693,603
6,866 Added 126.24%
12,305 $1.1 Million
Q4 2024

Jan 23, 2025

BUY
$96.31 - $114.76 $42,857 - $51,068
445 Added 8.91%
5,439 $541,000
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $54,241 - $62,937
488 Added 10.83%
4,994 $567,000
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $1,980 - $2,127
-16 Reduced 0.35%
4,506 $557,000
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $1,698 - $1,979
-15 Reduced 0.33%
4,522 $596,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $37,166 - $40,446
371 Added 8.91%
4,537 $494,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $36,135 - $40,129
351 Added 9.2%
4,166 $428,000
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $89,277 - $97,308
-822 Reduced 17.73%
3,815 $440,000
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $153,071 - $170,796
1,487 Added 47.21%
4,637 $493,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $275,436 - $353,146
3,150 New
3,150 $349,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $11,354 - $12,871
-136 Reduced 2.28%
5,828 $531,000
Q1 2022

Aug 15, 2022

BUY
$73.51 - $82.4 $438,413 - $491,433
5,964 New
5,964 $489,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $210B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Coastwise Capital Group, LLC Portfolio

Follow Coastwise Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastwise Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastwise Capital Group, LLC with notifications on news.